Schizophrenia stigma and mental disability：moderated mediation analysis

doi:10.12114/j.issn.1007-9572.2019.00.749

Abstract

Abstract: Background　Stigma is one of the important factors that cause mental disability in patients with schizophrenia.Previous studies have shown that stigma and hope are significantly correlated with mental disability of resilience，but the interaction mechanism between these factors is not yet clear.Objective　To explore the relationships among appearance comparison on stigma，mental disability，hope and resilience in schizophrenia.Methods　In Harbin BaiYuPao Psychiatric Hospital and the Third Hospital of Daqing，patients with schizophrenia were selected from September to December 2018 by convenient sampling method.WHO-DASⅡ，Internalized Stigma of Mental Illness Scale，Schizophrenia Hope Scale，Connor-Davidson Resilience Scale were used in this survey.Results　A total of 310 questionnaires were sent out and 304 valid questionnaires were returned，with valid response rate of 98.06%.Moderated mediation effect analysis suggested that，stigma positively predicted mental disability（P<0.01）.Both stigma and hope significant predicted mental disability（P<0.01）；and stigma significant predicted hope（P<0.01），hope affect partially mediated the relationship between stigma and mental disability.The product term of hope and resilience significant predicted mental disability（P<0.01），the mediating effect of hope was moderated by resilience.Conclusion　The stigma of schizophrenia not only has a mediated effect through hope but also a moderated effect through resilience on mental disability.

Key words: Schizophrenia, Mentally handicapped, Hope, Resilience, Stigma, Mediating effect, Predictive function

摘要： 背景　病耻感是造成精神分裂症患者精神残疾的重要影响因素之一，既往研究表明病耻感和希望、心理韧性、精神残疾呈显著相关关系，但各因素间相互作用机制尚未明确。目的　探讨病耻感与精神残疾的关系，以及希望与心理韧性的内在作用机制。方法　采用方便取样法，选取2018年9—12月哈尔滨市精神专科白渔泡医院和大庆市第三医院住院的精神分裂症患者。采用世界卫生组织残疾评定量表、精神疾病内在化病耻感量表、心理韧性量表、精神分裂症患者希望量表对患者进行调查。结果　共发放问卷310份，回收有效问卷304份，有效回收率为98.06%。有调节的中介效应分析表明，病耻感可显著正向预测精神残疾（P<0.01）；病耻感和希望对精神残疾的预测作用均显著（P<0.01），病耻感对希望的预测作用亦显著（P<0.01），希望在病耻感对精神残疾的影响中发挥部分中介作用；希望与心理韧性的乘积项对精神残疾的预测作用显著（P<0.01），心理韧性可在希望对精神残疾的预测作用中产生调节效应。结论　精神分裂症患者病耻感通过希望的中介作用和心理韧性的调节作用对精神残疾产生影响。

关键词: 精神分裂症, 精神残疾, 希望, 心理韧性, 病耻感, 中介效应, 预测作用

MAO Yingying,WANG Weiliang,LI Ci, et al. Schizophrenia stigma and mental disability：moderated mediation analysis[J]. Chinese General Practice, 2020, 23(20): 2509-2513. DOI: 10.12114/j.issn.1007-9572.2019.00.749.
毛英莹,王伟梁,李辞等. 精神分裂症患者病耻感与精神残疾的关系：有调节的中介效应分析[J]. 中国全科医学, 2020, 23(20): 2509-2513. DOI: 10.12114/j.issn.1007-9572.2019.00.749.

References

［1］FLEISCHHACKER W W，ARANGO C，ARTEEL P，et al．Schizophrenia——time to commit to policy change［J］．Schizophr Bull，2014，40（Suppl 3）：S165-194．DOI：10.1093/schbul/sbu006. ［2］WIERSMA D，WANDERLING J，DRAGOMIRECKA E，et al．Social disability in schizophrenia：its development and prediction over 15 years in incidence cohorts in six European centres［J］．Psychol Med，2000，30（5）：1155-1167．DOI： 10.1017/s0033291799002627. ［3］第二次全国残疾人抽样调查办公室.第二次全国残疾人抽样调查主要数据手册［M］．北京：华夏出版社，2007. ［4］RITSHER J B，PHELAN J C.Internalized stigma predicts erosion of morale among psychiatric outpatients［J］．Psychiatry Res，2004，129（3）：257-265．DOI：10.1016/j.psychres.2004.08.003. ［5］LIVINGSTON J D，BOYD J E.Correlates and consequences of internalized stigma for people living with mental illness：a systematic review and metaanalysis［J］．Soc Sci Med，2010，71（12）：2150-2161．DOI： 10.1016/j.socscimed.2010.09.030. ［6］CAVELTI M，RüSCH N，VAUTH R.Is living with psychosis demoralizing? Insight，self-stigma，and clinical outcome among people with schizophrenia across 1 year［J］．J Nerv Ment Dis，2014，202（7）：521-529．DOI： 10.1097/NMD.0000000000000160. ［7］LYSAKER P H，ROE D，YANOS P T.Toward understanding the insight paradox：internalized stigma moderates the association between insight and social functioning，hope，and self-esteem among people with schizophrenia spectrum disorders［ J］．Schizophr Bull，2007，33（1）：192-199．DOI：10.1093/schbul/sbl016. ［8］MCCAY E A，SEEMAN M V.A scale to measure the impact of a schizophrenic illness on an individual's self-concept［J］．Arch Psychiatr Nurs，1998，12（1）：41-49. ［9］COSKUN E，SAHIN ALTUN ?.The relationship between the hope levels of patients with schizophrenia and functional recovery［J］．Arch Psychiatr Nurs，2018，32（1）：98-102．DOI：10.1016/j.apnu.2017.10.006. ［10］LYSAKER P H，CLEMENTS C A，WRIGHT D E，et al．Neurocognitive correlates of helplessness，hopelessness，and well-being in schizophrenia［J］．J Nerv Ment Dis，2001，189（7）：457-462．DOI：10.1097/00005053-200107000-00007. ［11］MASTEN A S.Resilience in children threatened by extreme adversity：frameworks for research，practice，and translational synergy［J］．Dev Psychopathol，2011，23（2）：493-506．DOI：10.1017/S0954579411000198. ［12］MIHALI A，SUBRAMANI S，KAUNITZ G，et al．Modeling resilience to schizophrenia in genetically modified mice：a novel approach to drug discovery［J］．Expert Rev Neurother，2012，12（7）：785-799．DOI：10.1586/ern.12.60. ［13］TORGALSB?EN A K.Sustaining full recovery in schizophrenia after 15 years：does resilience matter?［J］．Clin Schizophr Relat Psychoses，2012，5（4）：193-200．DOI：10.3371/CSRP.5.4.3. ［14］JAKOBSEN K D，FREDERIKSEN J N，HANSEN T，et al．Reliability of clinical ICD-10 schizophrenia diagnoses［J］．Nord J Psychiatry，2005，59（3）：209-212．［15］何燕玲，张明园.阳性和阴性综合征量表（PANSS）及其应用［J］．临床精神医学杂志，1997，7（6）：353-355.http：//www.cnki.com.cn/Article/CJFDTotal-LCJS706.020.htm. ［16］王莲娥，周洁，金欢.世界卫生组织残疾评定量表第2版中文版在精神残疾评定中的信效度检验［J］．中国心理卫生杂志，2013，27（2）：121-125．DOI：10.3969/j.issn.1000-6729.2013.02.008. WANG L E，ZHOU J，JIN H.Reliability and validity of the Chinese version of WHO Disability Assessment Schedule 2.0 in mental disability assessment［J］．Chinese Mental Health Journal，2013，27（2）：121-125．DOI：10.3969/j.issn.1000- 6729.2013.02.008. ［17］RITSHER J B，OTILINGAM P G，GRAJALES M.Internalized stigma of mental illness：psychometric properties of a new measure［J］．Psychiatry Res，2003，121（1）：31-49．DOI：10.1016/j.psychres.2003.08.008. ［18］李强，高文珺，白炳清，等．心理疾病内化污名量表初步应用［J］．中国临床心理学杂志，2009，17（2）：127-130．DOI：10.16128/j.cnki.1005-3611.2009.02.001. LI Q，GAO W J，BAI B Q，et al．Preliminary application of internalized stigma of mental illness scale［J］．Chinese Journal of Clinical Psychology，2009，17（2）：127-130．DOI：10.16128/j.cnki.1005-3611.2009.02.001. ［19］CONNOR K M，DAVIDSON J R.Development of a new resilience scale：the Connor-Davidson Resilience Scale（CD-RISC）［J］．Depress Anxiety，2003，18（2）：76-82．DOI：10.1002/da.10113. ［20］YU X，ZHANG J.Factor analysis and psychometric evaluation of the Connor- Davidson Resilience Scale（CD-RISC）with Chinese people［J］．Soc Behav Pers，2007，35（1）：19-30. ［21］CHOE K.Development and preliminary testing of the Schizophrenia Hope Scale，a brief scale to measure hope in people with schizophrenia［J］．Int J Nurs Stud，2014，51（6）：927-933．DOI：10.1016/j.ijnurstu.2013.10.018. ［22］王伟梁，周郁秋，柴囡楠，等．精神分裂症患者希望量表中文版的心理测量学评价［J］．中国心理卫生杂志，2018，32（12）：982-985．DOI：10.3969/j.issn.1000-6729.2018.12.002. WANG W L，ZHOU Y Q，CHAI N N，et al．Psychometric properties of the Chinese version of the Schizophrenia Hope Scale［J］．Chinese Mental Health Journal，2018，32（12）：982-985．DOI：10.3969/j.issn.1000-6729.2018.12.002. ［23］周浩，龙立荣.共同方法偏差的统计检验与控制方法［J］．心理科学进展，2004，12（6）：942-950．DOI：10.3969/j.issn.1671-3710.2004.06.018. ZHOU H，LONG L R.Statistical remedies for common method biases［J］．Advances in Psychological Science，2004，12（6）：942-950．DOI：10.3969/j.issn.1671-3710.2004.06.018. ［24］GALDERISI S，ROSSI A，ROCCA P，et al．The influence of illness-related variables，personal resources and context-related factors on real-life functioning of people with schizophrenia［J］．World Psychiatry，2014，13（3）：275-287． DOI：10.1002/wps.20167. ［25］耿峰，董毅.精神疾病患者病耻感研究进展［J］．精神医学杂志，2010，23（2）：151-154．DOI：10.3969/j.issn.1009-7201.2010.02.028.http：//www.cnki.com.cn/Article/CJFDTotal-SDJB201002031.htm. ［26］LIEN Y J，CHANG H A，KAO Y C，et al．Self-stigma mediates the impact of insight on current suicide ideation in suicide attempters with schizophrenia：results of a moderated mediation approach［J］．Suicide Life Threat Behav，2018， 48（6）：661-676．DOI：10.1111/sltb.12384. ［27］VRBOVA K，PRASKO J，OCISKOVA M，et al．Quality of life，self-stigma，and hope in schizophrenia spectrum disorders：a cross-sectional study［J］．Neuropsychiatr Dis Treat，2017，13：567-576．DOI：10.2147/NDT.S122483. ［28］LAGGER N，AMERING M，SIBITZ I，et al．Stability and mutual prospective relationships of stereotyped beliefs about mental illness，hope and depressive symptoms among people with schizophrenia spectrum disorders［J］．Psychiatry Res ，2018，268：484-489．DOI：10.1016/j.psychres.2018.08.010. ［29］YANOS P T，ROE D，MARKUS K，et al．Pathways between internalized stigma and outcomes related to recovery in schizophrenia spectrum disorders［J］．Psychiatr Serv，2008，59（12）：1437-1442．DOI：10.1176/ps.2008.59.12.1437. ［30］刘东玮，周郁秋，李国华.社会支持与精神分裂症残疾：自尊与心理韧性的链式中介作用［J］．中国临床心理学杂志，2019，27（1）：78-82．DOI：10.16128/j.cnki.1005-3611.2019.01.016. LIU D W，ZHOU Y Q，LI G H.Social support and schizophrenia disability：the chain mediating role of self esteem and resilience［J］．Chinese Journal of Clinical Psychology，2019，27（1）：78-82．DOI：10.16128/j.cnki.1005-3611.2019.01.016. ［31］刘洋，沙丽艳，郭中献，等．维持性血液透析患者希望水平和心理弹性的相关性研究［J］．中国实用护理杂志，2016，32（35）：2739-2741．DOI：10.3760/cma.j.issn.1672-7088.2016.35.005.http//www.wanfangdata.com.cn/details/detail.do? _type=perio&id=syhlzz201635006.

[1]	WEN Min, ZHOU Yongling, LIU Jingjing, JIANG Keqing, LIU Juan, ZHU Xiaodan. The Effect and Mechanism of Compensatory Cognitive Training Based on mHealth APP on Stable Schizophrenia Patients [J]. Chinese General Practice, 2025, 28(22): 2819-2825.
[2]	LIU Caiping, ZHANG Yanhua, TANG Jianpin, WANG Chengpeng, XUE Fengfeng, WANG Huijuan, LI Chuanwei, ZHANG Guangya, LI Huafang. Efficacy and Safety of Long-acting Risperidone Microspheres in the Maintenance Treatment of Schizophrenia [J]. Chinese General Practice, 2025, 28(13): 1622-1627.
[3]	DONG Xiaomei, ZHAO Hongyan, GENG Zhongli, XU Tianchao, WANG Qi. The Effect of Cerebellar Vermal rTMS with TBS Paradigm on Negative Symptoms, Cognitive Function and Serum Inflammatory Factors in Elderly Patients with Chronic Schizophrenia: a Randomized Controlled Trial [J]. Chinese General Practice, 2025, 28(05): 575-580.
[4]	YUAN Yiqing, CHEN Honglin. Research Progress on Stigma of Cognitive Disorders [J]. Chinese General Practice, 2025, 28(05): 631-638.
[5]	QIN Wei, TU Gangying, WAN Xiaomei, WANG Fang. Effects of Balance-strengthening Training on Balance Ability in Elderly Inpatients with Schizophrenia: a Randomized Controlled Trial [J]. Chinese General Practice, 2025, 28(02): 193-199.
[6]	FENG Tianxiao, WANG Xu, BU Hanmei, QIN Xiaokuan, XIAO Xiangyu, WEI Xu, ZHU Liguo. Study on the Evidence Map of Manual Therapy of Clinical Advantageous Diseases in Traditional Chinese Orthopedics [J]. Chinese General Practice, 2024, 27(32): 4021-4028.
[7]	FENG Tianxiao, SUN Kai, QIN Xiaokuan, WANG Xu, BU Hanmei, ZHU Liguo, WEI Xu. Development Status, Challenges, and Strategies of Clinical Practice Guidelines in Traditional Chinese Medicine Orthopedics [J]. Chinese General Practice, 2024, 27(31): 3850-3856.
[8]	ZHANG Yasi, ZHANG Jing, XU Chen, SUN Yujing, BAI Yinjie. Psychological Resilience Scale for Cancer Patients: a Systematic Review Based on COSMIN Guidelines [J]. Chinese General Practice, 2024, 27(29): 3664-3671.
[9]	HAN Huanxia, FAN Chunlei, WANG Ligang, TAO Ting, GAO Wenbin. Mediating Effect of Self-regulatory Fatigue and Moderating Effect of Health Literacy in the Relationship between Occupational Stress and Mental Health in Lawyers [J]. Chinese General Practice, 2024, 27(21): 2607-2616.
[10]	YANG Cuicui, WANG Yubing, XU Jingjing, LUO Dan. Reliability and Validity of the Chinese Version of Type 1 Diabetes Stigma Assessment Scale for Adolescents [J]. Chinese General Practice, 2024, 27(18): 2253-2259.
[11]	Schizophrenia Coordination Group, Chinese Society of Psychiatry, Chinese Society of General Practice, LI Qian, SI Tianmei. Benefits of Community-based Treatment for Patients with Schizophrenia: Based on Long-acting Injectable Antipsychotic Agents [J]. Chinese General Practice, 2024, 27(09): 1021-1027.
[12]	XU Yanan, LI Wenjuan, ZHAO Shuqin, TANG Yuji, YUAN Fuqiang, ZHAO Kunpeng. A Qualitative Study on the Social Isolation Experience of Young and Middle-aged Patients with Schizophrenia in Remission [J]. Chinese General Practice, 2024, 27(09): 1088-1094.
[13]	ZHANG Siyu, ZHOU Yuqiu, DU Xiaohui, WANG Zhengjun. Advances in Duration of Untreated Psychosis and Its Early Intervention [J]. Chinese General Practice, 2023, 26(33): 4110-4117.
[14]	LI Qian, ZHANG Yunshu, YAN Baoping, WANG Jian, MA Yanjuan, WANG Yuan, QIN Yingjie, NA Long, REN Zhiyong, SUN Junwei, DENG Huaili, MA Hongjun, QU Xuehui, ZHOU Nan, SI Tianmei. Efficacy and Safety of Risperidone Microspheres for Injection (Ⅱ) in the Treatment of Patients with Acute Schizophrenia [J]. Chinese General Practice, 2023, 26(32): 4007-4012.
[15]	LUO Dan, XU Jingjing, WANG Yubing, LI Mingzi, FORBES Angus. Development and Preliminary Practice of Resilience-oriented Structured Treatment and Educational Program for Adolescents with Type 1 Diabetes [J]. Chinese General Practice, 2023, 26(27): 3423-3429.